Next Article in Journal
Management of Extra-Pelvic Varicose Veins of Pelvic Origin in Female Patients
Previous Article in Journal
Management of Hemodynamic and Respiratory Instability and Anesthetic Approaches in Patients Undergoing Pulmonary Thrombectomy for Pulmonary Embolism
Previous Article in Special Issue
Pediatric Chronic Kidney Disease During Pandemic Conditions—A Single-Center Experience
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Post-Dialysis Fatigue Is Not Associated with Serum Lactate Levels in Patients on Chronic Hemodialysis

1
Servizio Emodialisi, Dipartimento di Scienze Mediche e Chirurgiche, Università Cattolica del Sacro Cuore, 00168 Roma, Italy
2
Policlinico Universitario Fondazione Agostino Gemelli IRCCS, 00168 Roma, Italy
3
Divisione di Nefrologia, Servizio Emodialisi, Dipartimento di Scienze Mediche e Chirurgiche, Università Cattolica del Sacro Cuore, 00168 Roma, Italy
4
Dipartimento di Nefrologia, Ospedale “Carlo Urbani” Jesi, 60035 Jesi, Italy
5
Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Roma, Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(8), 2706; https://doi.org/10.3390/jcm14082706
Submission received: 21 March 2025 / Revised: 8 April 2025 / Accepted: 14 April 2025 / Published: 15 April 2025
(This article belongs to the Special Issue Clinical Epidemiology in Chronic Kidney Disease)

Abstract

:
Background/Objectives: To measure the peri-dialytic serum lactate, sodium, potassium, calcium, and pH and base excess in chronic hemodialysis patients with and without post-dialysis fatigue (PDF). Methods: Patients were asked “Do you feel fatigued after dialysis?” Each patient was invited to rate the intensity, duration, and frequency of PDF from one to five. The recovery time after the hemodialysis session (TIRD) was calculated, and inviting patients were to answer the following single open-ended question: “How long does it take you to recover from a dialysis session?” Pre- and post-dialysis arterial blood was sampled, and pH, bicarbonates, base excess, sodium, calcium, potassium, and lactate were measured. Results: One hundred fifty-eight patients were included in the study. One hundred seventeen patients declared to suffer from PDF and forty-one did not. Median [range] PDF frequency, intensity, duration, and TIRD were 5 (1–5), 4 (1–5), 3 (1–5), and 12 h (1–48), respectively. Seventy patients had a TIRD ≤ 12 h and forty-seven had a TIRD > 12 h. Median post-dialysis and post-dialysis/pre-dialysis difference serum lactate levels (mmol/L) did not differ between patients with and without PDF (p = 0.111 and p = 0.395, respectively). In addition, the distribution of patients according to post-dialysis serum lactate levels was similar in the presence or absence of PDF. The median post-dialysis and post-dialysis/pre-dialysis difference serum lactate concentrations did not differ significantly according to the score of the PDF intensity and PDF duration (p = 0.928 and 0.935, p = 0.610 and 0.548, respectively). Finally, we stratified patients into two groups according to the length of TIRD: ≤12 h and >12 h. The median post-dialysis serum lactate concentrations did not differ significantly between the two groups (p = 0.862) as well as the median post-dialysis/pre-dialysis difference (p = 0.583). Also, the distribution of patients according to post-dialysis serum lactate levels was similar in the two groups. Conclusions: PDF and TIRD are not associated with peri-dialytic changes in serum lactate in patients on chronic hemodialysis.

1. Introduction

Many patients, following a hemodialysis treatment, report to feel tired and the need for a rest or sleeping time. This condition, conventionally called post-dialysis fatigue (PDF), has been described as a feeling of being worn out, drained, or exhausted [1,2,3]. PDF is one of the most debilitating symptoms of hemodialysis patients, significantly impairing their quality of life and causing frustration and depression [1,2,3].
PDF is common, although prevalence estimates vary between studies from 20% to 86%, and differences in estimates are likely related to different inclusion criteria, ascertainment methods, or definitions of fatigue [1,2,3].
The causes and the pathogenesis of PDF are essentially unknown [1,2,3,4]. However, some mechanisms have been proposed, such as (1) the rapid decline in osmolarity occurring during dialysis as a result of the combined effect of a reduction in serum urea and sodium concentration (this leads to brain swelling and headache, restlessness, nausea, muscle cramps, and fatigue) [5,6]; (2) the release of cytokines such as interleukin-1, interleukin-6, and tumour necrosis factor-alpha [7,8,9]; and (3) the accumulation of metabolites and toxins in the muscle. In addition, the data point also to psychological factors contributing to PDF [1,2,3,4]. Referring to the third point, it has been suggested that intradialytic hypotension, one of the most common complications of hemodialysis, may contribute to muscle ischemia, accumulation of lactate in the muscle, high serum lactate levels, and consequent muscle fatigue and PDF [10,11,12,13]. These data are supported by the observation that higher levels of post-dialysis lactate are associated with PDF in patients on chronic hemodialysis and, in particular, that post-dialysis lactate levels in patients with severe PDF were significantly higher than that in patients with mild PDF [12]. It is hypothesised that microcirculatory dysfunction can cause regional tissue hypoxia and consequent hyperlactatemia [12]. Unfortunately, to the best of our knowledge, there is no evidence of other studies on this issue. The present study aims to measure the peri-dialytic serum lactate concentrations in end-stage renal disease (ESRD) patients on chronic hemodialysis and to define the possible correlation with PDF prevalence and characteristics as well with the length of the time of recovery after dialysis (TIRD) defined as the time taken to recover from a dialysis session.

2. Patients and Methods

All prevalent ESRD patients receiving chronic hemodialysis at our hospital in December 2024 were eligible for inclusion in the study. Exclusion criteria were as follows: dialysis duration <1 year, diagnosis of dementia based on DSM-IV criteria, presence of acute infectious disease, presence of active cancer, vascular access though a central venous catheter, heart failure, respiratory failure, haemorrhage, severe infections, alcohol abuse, shock, and liver disease [13]. The study was performed in adherence to the Declaration of Helsinki, and the protocol was approved by the local ethics committee (Prot ID 3169). Written informed consent was obtained from all participants before enrolment in the study. For each participant, the following parameters were recorded at the time of inclusion in the study: age, gender, underlying renal disease, weight, height, hemodialysis regimen, type and number of comorbid conditions, and the Charlson Comorbidity Index [14].

2.1. Identification and Grading of PDF

The assessment of PDF was conducted according to the studies of Sklar et al. [15]. Each patient was interviewed during one of the patient’s regularly scheduled treatments. Patients were suffering from PDF if they spontaneously offered this complaint when asked the open-ended question: “Do you feel fatigued after dialysis?” Then, each patient was invited to rate the intensity, duration, and frequency of PDF from 1 to 5.

2.2. Other Measurements

The recovery time after the hemodialysis session (TIRD) was calculated according to Lindsay et al. [16]. Briefly, patients were invited to answer to the following single open-ended question: “How long does it take you to recover from a dialysis session?”
Functional ability was estimated using the Katz activities of daily living (ADLs), and the Lawton and Brody scale for instrumental activities of daily living (IADLs) [17,18]. These scales are most adopted for assessing functional independency for clinical and epidemiological purposes; disability in the ADLs was defined as need of assistance for performing two or more ADLs. The reason for not choosing a single-point decline is that impairment in two ADLs is less likely to capture physiological fluctuations in functional performance. Impairment in IADL function was identified by a score <7; this higher cut-off level is generally adopted to avoid a “floor effect”. The ADL scale is based on seven levels of self-performance including dressing, eating, toilet use, bathing, mobility in bed, locomotion, and transfer. Similarly, the IADL scale is based on seven levels of self-performance including meal preparation, housework, managing finance, phone use, shopping, transportation, and managing medications. Finally, the Kt/V was calculated according to a standard formula and used as an index of adequacy of the hemodialysis treatment.

2.3. Hemodialysis

All patients received conventional 4 h bicarbonate hemodialysis three times a week. The blood flow ranged from 250 to 300 mL/min with a dialysis rate flow of 500 mL/min. All patients were treated with high-permeability membranes.

2.4. Laboratory Measurements

Blood samples were obtained from HD patients directly through the arteriovenous fistula before their scheduled HD session at the beginning of the week. Serum was separated within 30 min, and samples were kept frozen at −70 °C if not analysed immediately. Laboratory parameters were measured by routine methods at the Department of Diagnostic and Laboratory Medicine, Unity of Chemistry, Biochemistry and Clinical Molecular Biology. Pre- and post-dialysis arterial blood was sampled from the arterial blood line of the arteriovenous fistula, and the following parameters were tested: pH, actual bicarbonate, base excess, sodium, potassium, and lactate (arterial blood gas analysis).

2.5. Statistical Analyses

Statistical analysis was performed using the Statistical Package for Social Science (SPSS), release 15.0. Continuous variables were expressed as mean ± SD, categorical variables displayed as frequencies, and the appropriate parametric or non-parametric test was used to assess significance of the differences between groups. All data were first analysed for normality of distribution using the Kolmogorov–Smirnov test of normality. Correlations were calculated with the Spearman’s rho correlation coefficient. After adjustment for multiple measures, a p-value < 0.01 was considered statistically significant. Correlation Matrix of Fatigue and hemogas analysis parameters were built, reporting Spearman’s rho and significance values. The primary outcome was defined as the difference between pre- and post-dialysis serum lactate levels according to the presence of PDF or TIRD class (≤ or >12 h). Considering α = 0.05, power = 80%, and the number of enrolled subjects, effect sizes of 0.51 and 0.53 were calculated for PDF presence and TIRD class, respectively; our observed effect sizes (0.1 units for both variables) are significantly lower, thus confirming the absence of association between lactate and PDF or TIRD. As shown in Table 1, no differences in baseline demographical, clinical, and laboratory characteristics between PDF presence and absence subgoups were detected, thus warranting no further confounding factor controls through the data analysis.

3. Results

One hundred fifty-eight patients were included in the study. Their demographic, clinical, and laboratory characteristics are shown in Table 1. One hundred seventeen patients declared to suffer PDF (group A) and forty-one did not (group B). Median [95% CI] PDF frequency was four (five to five). Median [95% CI] PDF intensity was three (three to four). Median [95% CI] PDF duration was three (two to three). The median [95% CI] TIRD was 12 h (11.9 to 12). Seventy patients had a TIRD ≤ 12 h and forty-seven had one >12 h.
The pre-dialysis and post-dialysis serum pH and concentrations of bicarbonates, sodium, calcium, potassium, lactate, and base excess are shown in Table 2, either in patients with or without PDF. As expected, in both groups (A and B), a significant increase in pH, bicarbonates, calcium, sodium, and base excess and a significant decrease in potassium and lactate was observed between pre- and post-dialysis assessments.
As shown in Table 3, the median [95% CI] post-dialysis serum lactate levels (mmol/L) and the median [95% CI] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) did not differ between patients with and without PDF. In addition, the distribution of patients according to post-dialysis serum lactate levels was similar in the presence or absence of PDF (Table 4).
The median [95% CI] post-dialysis serum lactate concentrations did not differ significantly according to the score of the PDF intensity and PDF duration (Table 5). In addition, the median [min–max] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) were similar with regards to the PDF characteristics (Table 6).
Then, we stratified patients into two groups according to the length of TIRD: ≤12 h and >12 h. The median [95% CI] post-dialysis serum lactate concentrations did not differ significantly between the two groups as well as the median [min–max] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) (Table 7). Also, the distribution of patients according to post-dialysis serum lactate levels was similar in the two groups (Table 8). As shown in Figure 1 and Figure 2, the correlations between TIRD and post-dialysis serum lactate levels and between TIRD and Δ post-dialysis/pre-dialysis serum lactate levels, respectively, were not statistically significant.
Any significant associations between post-dialysis pH, serum base excess, and serum sodium and serum potassium levels with PDF, PDF characteristics, and TIRD were observed.

4. Discussion

The present study shows that the difference in peri-dialytic levels of serum lactate as well as the post-dialysis serum lactate levels are not associated with PDF frequency, PDF characteristics, and TIRD in patients on maintenance hemodialysis. These results are inconsistent with those of Zu et al., showing that mean post-dialysis serum lactate levels were significantly higher in patients with severe PDF than in those with no or mild PDF, and that higher post-dialysis lactate levels were associated with PDF [12]. With respect to the study of Zu et al., we did not stratify patients according to the severity of PDF (mild or severe). Alternatively, according to the study of Sklar et al. [3], we invited patients to grade the intensity, duration, and frequency of PDF on a scale from one to five. Interestingly, the median [95% CI] post-dialysis serum lactate concentrations did not differ significantly according to the score of the PDF intensity and PDF duration, and the the median [min–max] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) were similar with regards to the PDF characteristics. This methodological difference in the assessment of PDF severity may, at least in part, explain the different results between our study and the study of Zu et al. [12].
Reference limits for serum lactate are reported as >2 mmol/l [19]. The present study demonstrates that the frequency of post-dialysis serum lactate >2 mmol/l and >4 mmol/L is similar in patients with and without PDF and in patients with TIRD length below and above the median value. Similarly, in the study of Zu et al., the frequency of post-dialysis serum lactate levels >2 mmol/l did not differ significantly among patients with no PDF, mild PDF, and severe PDF [12].
The results of the present study argue against the hypothesis that PDF may be the results of peripheral muscle metabolic alterations related to serum lactate levels. In fact, it has been suggested that intradialytic hypotension, one of the most common complications of hemodialysis, may contribute to skeletal muscle ischemia and consequent lactate accumulation, high serum lactate levels, muscle fatigue, and PDF [1,2,3,20,21]. In the present study, hypotensive event frequency did not differ significantly between patients with and without PDF, and this might explain, at least in part, the lack of association between PDF and serum lactate levels. Generally, accumulation of lactate in skeletal muscle and the consequent decrease in cellular pH have been considered to contribute to muscle fatigue [20,21,22]. However, the contemporary view is that lactate is no longer considered a metabolic waste product and cause of muscle fatigue but instead a myokine or exerkine with autocrine-, paracrine-, and endocrine-like functions [23,24,25,26].
In the present study, we also show that the association between the differences in peri-dialytic serum sodium concentrations with PDF, PDF characteristics, and TIRD were not statistically significant. Interestingly, some authors found that the post-dialysis serum sodium levels were significantly lower in patients with PDF than in patients without [12]. This discrepancy between our study and the study of Zu et al. [12] is difficult to explain and requires further study. Nevertheless, there is evidence that low dialysate sodium concentration leading to low post-dialysis serum sodium concentration is not associated with post-dialysis fatigue or general fatigue in patients on chronic hemodialysis [27,28].
Metabolic acidosis is commonly retained to be associated with fatigue in ESRD patients on chronic hemodialysis [29]. Indeed, there is lack of evidence to support this statement. Nevertheless, the observation in the present study of any significant association between the difference in peri-dialytic pH and serum base excess with PDF, PDF characteristics, and TIRD argues against this hypothesis. In addition, the increase in in intracellular muscle acidosis has been demonstrated not to be a central factor underlying the impaired contractile function in fatigued mammalian muscle [30].
We also found significant association between the difference in peri-dialytic serum potassium and PDF, PDF characteristics, and TIRD. It has been demonstrated, recently, that the membrane in patients on chronic hemodialysis is depolarised, mainly due to hyperkalemia, and it has been argued that this potassium-induced depolarisation resembles that in fatigued muscle [31]. In the present study, the pre-dialysis serum potassium levels (mmol/L) were 4.9 (4.6–5.2) and 4.9 (4.7–5.3) in patients with and without PDF, respectively, and this may possibly explain the lack of association with PDF and TIRD.
The present study has some limitations. First, being observational and crossover, no conclusion can be drawn about causality. Second, the single center of the study population can restrict generalisability. Third, the study relied on self-reported measures for PDF and TIRD. Nevertheless, numerous studies, in the past, have shown that these measures are accurate and reliable [3,4,6,8,15,16,28,30,32,33,34,35].
In conclusion, PDF is not associated with pre-dialysis, post-dialysis, and peri-dialytic changes in serum lactate in patients on chronic hemodialysis. Post-dialysis fatigue in chronic hemodialysis patients is a complex phenomenon and a multifactorial origin, with relevant roles of behavioural, social, and psychological factors [36]. Therefore, it is amenable to consider both, biochemical and psychosocial variables, when trying to unravel the aetiology of PDF in patients on chronic hemodialysis.

Author Contributions

Methodology, M.B. and I.M.; validation, I.M., T.M. and E.D.S.; formal analysis, M.B., N.C., I.M., T.M., S.S. and E.D.S.; investigation, M.B., N.C., I.M., S.S. and E.D.S.; resources, T.M.; data curation, M.B., N.C., I.M., S.S. and E.D.S.; writing—original draft, M.B., N.C., I.M., T.M., S.S. and E.D.S.; writing—review & editing, M.B., N.C., T.M., S.S. and E.D.S.; supervision, M.B. and T.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics committee is of the Università cattolica del sacro cuore of Rome. The date of approval is 8 January 2011 (protocol number: P606/CE/2011).

Informed Consent Statement

Written informed consent was obtained from all participants.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. You, Q.; Bai, D.X.; Wu, C.X.; Chen, H.; Hou, C.M.; Gao, J. Prevalence and Risk Factors of Postdialysis Fatigue in Patients Under Maintenance Hemodialysis: A Systematic Review and Meta-Analysis. Asian Nurs. Res. (Korean Soc. Nurs. Sci.) 2022, 16, 292–298. [Google Scholar] [CrossRef] [PubMed]
  2. Bossola, M.; Tazza, L. Postdialysis Fatigue: A Frequent and Debilitating Symptom. Semin. Dial. 2016, 29, 222–227. [Google Scholar] [CrossRef] [PubMed]
  3. Sklar, A.H.; Riesenberg, L.A.; Silber, A.K.; Ahmed, W.; Ali, A. Postdialysis fatigue. Am. J. Kidney Dis. 1996, 28, 732–736. [Google Scholar] [CrossRef] [PubMed]
  4. Bossola, M.; Marzetti, E.; Di Stasio, E.; Monteburini, T.; Cenerelli, S.; Mazzoli, K.; Parodi, E.; Sirolli, V.; Santarelli, S.; Ippoliti, F.; et al. Prevalence and associated variables of post-dialysis fatigue: Results of a prospective multicentre study. Nephrology 2018, 23, 552–558. [Google Scholar] [CrossRef]
  5. Gordon, P.L.; Doyle, J.W.; Johansen, K.L. Postdialysis fatigue is associated with sedentary behavior. Clin. Nephrol. 2011, 75, 426–433. [Google Scholar]
  6. Sklar, A.; Newman, N.; Scott, R.; Semenyuk, L.; Schultz, J.; Fiacco, V. Identification of factors responsible for postdialysis fatigue. Am. J. Kidney Dis. 1999, 34, 464–470. [Google Scholar] [CrossRef]
  7. Dreisbach, A.W.; Hendrickson, T.; Beezhold, D.; Riesenberg, L.A.; Sklar, A.H. Elevated levels of tumor necrosis factor alpha in postdialysis fatigue. Int. J. Artif. Organs 1998, 21, 83–86. [Google Scholar] [CrossRef]
  8. Brys, A.; Stasio, E.D.; Lenaert, B.; Picca, A.; Calvani, R.; Marzetti, E.; Gambaro, G.; Bossola, M. Peridialytic serum cytokine levels and their relationship with postdialysis fatigue and recovery in patients on chronic haemodialysis—A preliminary study. Cytokine 2020, 135, 155223. [Google Scholar] [CrossRef]
  9. Bossola, M.; Di Stasio, E.; Giungi, S.; Rosa, F.; Tazza, L. Fatigue is associated with serum interleukin-6 levels and symptoms of depression in patients on chronic hemodialysis. J. Pain. Symptom Manag. 2015, 49, 578–585. [Google Scholar] [CrossRef]
  10. Seong, E.Y.; Zheng, Y.; Winkelmayer, W.C.; Montez-Rath, M.E.; Chang, T.I. The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study. Clin. J. Am. Soc. Nephrol. 2018, 13, 1517–1525. [Google Scholar] [CrossRef]
  11. MacEwen, C.; Sutherland, S.; Daly, J.; Pugh, C.; Tarassenko, L. Relationship between Hypotension and Cerebral Ischemia during Hemodialysis. J. Am. Soc. Nephrol. 2017, 28, 2511–2520. [Google Scholar] [CrossRef] [PubMed]
  12. Zu, Y.; Lu, X.; Yu, Q.; Yu, L.; Li, H.; Wang, S. Higher Postdialysis Lactic Acid Is Associated with Postdialysis Fatigue in Maintenance of Hemodialysis Patients. Blood Purif. 2020, 49, 535–541. [Google Scholar] [CrossRef] [PubMed]
  13. Antinone, R.; Kress, T. Measuring serum lactate. Nurs. Crit. Care 2009, 4, 56. [Google Scholar] [CrossRef]
  14. Di Iorio, B.; Cillo, N.; Cirillo, M.; De Santo, N.G. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization. Int. J. Artif. Organs 2004, 27, 330–336. [Google Scholar] [CrossRef]
  15. Sklar, A.H.; Beezhold, D.H.; Newman, N.; Hendrickson, T.; Dreisbach, A.W. Postdialysis fatigue: Lack of effect of a biocompatible membrane. Am. J. Kidney Dis. 1998, 31, 1007–1010. [Google Scholar] [CrossRef]
  16. Lindsay, R.M.; Heidenheim, P.A.; Nesrallah, G.; Garg, A.X.; Suri, R.; Daily Hemodialysis Study Group London Health Sciences Centre. Minutes to recovery after a hemodialysis session: A simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin. J. Am. Soc. Nephrol. 2006, 1, 952–959. [Google Scholar] [CrossRef]
  17. Katz, S.; Ford, A.B.; Moskowitz, R.W.; Jackson, B.A.; Jaffe, M.W. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963, 185, 914–919. [Google Scholar] [CrossRef]
  18. Lawton, M.P.; Brody, E.M. Assessment of older people: Self-maintaining and Instrumental Activities of Daily Living. Gerontology 1969, 9, 179–186. [Google Scholar] [CrossRef]
  19. Finsterer, J.; Milvay, E. Lactate stress testing in 155 patients with mitochondriopathy. Can. J. Neurol. Sci. 2002, 29, 49–53. [Google Scholar] [CrossRef]
  20. Fitts, R.H. Cellular mechanisms of muscle fatigue. Physiol. Rev. 1994, 74, 49–94. [Google Scholar] [CrossRef]
  21. Westerblad, H.; Lee, J.A.; Lännergren, J.; Allen, D.G. Cellular mechanisms of fatigue in skeletal muscle. Am. J. Physiol. 1991, 261, C195–C209. [Google Scholar] [CrossRef] [PubMed]
  22. Finsterer, J. Biomarkers of peripheral muscle fatigue during exercise. BMC Musculoskelet. Disord. 2012, 13, 218. [Google Scholar] [CrossRef] [PubMed]
  23. Brooks, G.A.; Osmond, A.D.; Arevalo, J.A.; Duong, J.J.; Curl, C.C.; Moreno-Santillan, D.D.; Leija, R.G. Lactate as a myokine and exerkine: Drivers and signals of physiology and metabolism. J. Appl. Physiol. 2023, 134, 529–548. [Google Scholar] [CrossRef] [PubMed]
  24. Hall, M.M.; Rajasekaran, S.; Thomsen, T.W.; Peterson, A.R. Lactate: Friend or Foe. PM R 2016, 8 (Suppl. S3), S8–S15. [Google Scholar]
  25. Cairns, S.P. Lactic acid and exercise performance: Culprit or friend? Sports Med. 2006, 36, 279–291. [Google Scholar] [CrossRef]
  26. Lee, S.; Choi, Y.; Jeong, E.; Park, J.; Kim, J.; Tanaka, M.; Choi, J. Physiological significance of elevated levels of lactate by exercise training in the brain and body. J. Biosci. Bioeng. 2023, 135, 167–175. [Google Scholar] [CrossRef]
  27. Dunlop, J.L.; Vandal, A.C.; Marshall, M.R. Low dialysate sodium levels for chronic haemodialysis. Cochrane Database Syst. Rev. 2019, 1, CD011204. [Google Scholar] [CrossRef]
  28. Bossola, M.; Di Stasio, E.; Monteburini, T.; Parodi, E.; Ippoliti, F.; Bonomini, M.; Santarelli, S.; Eugenio Nebiolo, P.; Sirolli, V.; Cenerelli, S. Intensity, Duration, and Frequency of Post-Dialysis Fatigue in Patients on Chronic Haemodialysis. J. Ren. Care. 2020, 46, 115–123. [Google Scholar] [CrossRef]
  29. Kovacic, V.; Roguljic, L.; Kovacic, V. Metabolic acidosis of chronically hemodialyzed patients. Am. J. Nephrol. 2003, 23, 158–164. [Google Scholar] [CrossRef]
  30. Westerblad, H. Acidosis is not a significant cause of skeletal muscle fatigue. Med. Sci. Sports Exerc. 2016, 48, 2339–2342. [Google Scholar] [CrossRef]
  31. Larsen, L.H.; Z’Graggen, W.J.; Bostock, H.; Tan, S.V.; Buus, N.H.; Tankisi, H. The role of potassium in muscle membrane dysfunction in end-stage renal disease. Clin. Neurophysiol. 2021, 132, 3125–3135. [Google Scholar] [CrossRef] [PubMed]
  32. Bossola, M.; Di Giovanni, M.; Mariani, I.; Di Stasio, E.; Angioletti, L.; Balconi, M. Post-Dialysis Fatigue Is Not Associated With Perceived Stress in Patients on Hemodialysis. Hemodial. Int. 2025, 29, 214–221. [Google Scholar] [CrossRef] [PubMed]
  33. Bossola, M.; Monteburini, T.; Parodi, E.; Santarelli, S.; Sirolli, V.; Cenerelli, S.; Bonomini, M.; de Ninno, G.; di Stasio, E. Post-dialysis fatigue: Comparison of bicarbonate hemodialysis and online hemodiafiltration. Hemodial. Int. 2023, 27, 55–61. [Google Scholar] [CrossRef] [PubMed]
  34. Bossola, M.; Picca, A.; Marzetti, E.; Pepe, G.; Antocicco, M.; Di Stasio, E. Post-dialysis fatigue and serum S100B protein in patients on chronic hemodialysis. A pilot study. Ther. Apher. Dial. 2023, 27, 471–479. [Google Scholar] [CrossRef]
  35. Bossola, M.; Picca, A.; Monteburini, T.; Parodi, E.; Santarelli, S.; Cenerelli, S.; Sirolli, V.; Bonomini, M.; Di Stasio, E. Post-dialysis fatigue and survival in patients on chronic hemodialysis. J. Nephrol. 2021, 34, 2163–2165. [Google Scholar] [CrossRef]
  36. Bossola, M.; Hedayati, S.S.; Brys, A.D.H.; Gregg, L.P. Fatigue in Patients Receiving Maintenance Hemodialysis: A Review. Am. J. Kidney Dis. 2023, 82, 464–480. [Google Scholar] [CrossRef]
Figure 1. Correlation between TIRD and post-dialysis serum lactate levels. Correlation coefficient = 0.02504; p = 0.790.
Figure 1. Correlation between TIRD and post-dialysis serum lactate levels. Correlation coefficient = 0.02504; p = 0.790.
Jcm 14 02706 g001
Figure 2. Correlation between TIRD and Δ post-dialysis/pre-dialysis serum lactate levels. Correlation coefficient = 0.017; p = 0.843.
Figure 2. Correlation between TIRD and Δ post-dialysis/pre-dialysis serum lactate levels. Correlation coefficient = 0.017; p = 0.843.
Jcm 14 02706 g002
Table 1. Baseline demographical, clinical, and laboratory characteristics. Data are shown as mean ± standard deviation or median [95% CI for the median] for continuous variables. PDF: post-dialysis fatigue; CCI: Charlson Comorbidity Index; ADL: activity of daily living; IADL, instrumental activity of daily living.
Table 1. Baseline demographical, clinical, and laboratory characteristics. Data are shown as mean ± standard deviation or median [95% CI for the median] for continuous variables. PDF: post-dialysis fatigue; CCI: Charlson Comorbidity Index; ADL: activity of daily living; IADL, instrumental activity of daily living.
PDF Absent
(n = 41)
PDF Present
(n = 117)
p
Age (years)66.2 ± 10.968.5 ± 11.20.256
Sex: male/female31:1073:440.179
Dialysis age, months47.5 ± 45.654.5 ± 53.20.453
Primary cause of ESRD (n)
hypertension 1642
glomerulonephritis 1028
diabetes 822
interstitial nephritis 410
polycystic kidney disease 29
others/unknown160.964
BMI23.3 ± 3.323.8 ± 3.50.482
CCI2 (0–6)2 (0–7)0.927
ADL5 (0–5)5 (0–6)0.786
IADL 6 (0–8)6 (0–7)0.457
TIRD (hours)2 (2 to 2)12 (12 to 12)<0.001
Weight gain (Kg)2.7 ± 1.22.4 ± 1.30.254
Kt/Vurea 1.28 ± 0.41.32 ± 0.30.562
QB (mL/min)268 ± 31258 ± 340.146
Haemoglobin (g/dL) 10.8 ± 0.410.7 ± 0.60.377
Serum albumin (mg/dL)3.63 ± 0.43.71 ± 0.50.412
Serum creatinine (mg/dL) 10.8 ± 2.511.3 ± 3.40.443
Dialysate sodium (mmol/L)139 ± 1.2139 ± 1.60.745
Dialysate temperature (°C)36.4 ± 0.336.5 ± 0.40.195
Table 2. Laboratory variables and PDF. PDF: post-dialysis fatigue. Data are shown as median [95% CI].
Table 2. Laboratory variables and PDF. PDF: post-dialysis fatigue. Data are shown as median [95% CI].
PRE-DIALYSISPOST-DIALYSIS
PDF NOPDF YESpPDF NOPDF YESp
pH7.33 (7.31–7.46)7.33 (7.31–7.34)0.2887.43 (7.70–7.46)7.42 (7.41–7.44)0.438
Bicarbonates (mmol/L)18.1 (16.8–20.3)19 (18.2–19.9)0.51223.3 (21.6–25.2)24.2 (23.2–24.7)0.604
Base excess (mmol/L)−6.25 (−8.15–−4.63)−5.9 (−6.9–−4.6)0.6700.5 (1.9–1.35)0.5 (−0.4–1.25)0.514
Sodium (mmol/L)138 (137–139.2)139 (137.6–140)0.729140.6 (140–141)140 (139.9–141)0.828
Potassium
(mmol/L)
4.9 (4.6–5.2)4.9 (4.7–5.3)0.8273.7 (3.6–3.8)3.7 (3.6–3.8)1.000
Lactate (mmol/L)0.9 (0.8–1.2)1.2 (1.1–1.4)0.0120.8 (0.2–1)1.1 (0.9–1.2)0.090
Table 3. Median [95% CI] post-dialysis serum lactate levels (mmol/L) and median [95% CI] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) and PDF.
Table 3. Median [95% CI] post-dialysis serum lactate levels (mmol/L) and median [95% CI] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) and PDF.
PDF Absent
(n = 41)
PDF Present
(n = 117)
p
Post-dialysis serum lactate levels0.8 (0.7–1.0)1.1 (0.9–1.2)0.090
Δ Post-dialysis/pre-dialysis serum lactate−0.1 (−0.4–0.08)−0.2 (−0.4–−0.1)0.490
Table 4. Distribution of patients according to post-dialysis serum lactate levels and PDF.
Table 4. Distribution of patients according to post-dialysis serum lactate levels and PDF.
Post-Dialysis Serum Lactate LevelsPDF Absent
(n = 41)
PDF Present
(n = 117)
p
0.5–2.0 mmol/L411100.191
2.1–4.0 mmol/L07
≥4.0 mmol/L00
Table 5. Median [min–max] post-dialysis serum lactate levels (mmol/L) and PDF characteristics.
Table 5. Median [min–max] post-dialysis serum lactate levels (mmol/L) and PDF characteristics.
12345p
PDF intensity1.1 (0.8–1.9)1.3 (0.2–2.8)1.1 (0–3)1.1 (0.03–2.1)0.9 (0.2–2.2)0.516
PDF duration1.4 (0.2–2.8)0.8 (0.03–2.2)1 (0.2–2)0.8 (0–3)0.9 (0.3–2.7)0.057
PDF frequency1.3 (0.4–2.8)0.9 (0.2–2)1.7 (0.6–2.1)0.7 (0.3–1.5)0.8 (0–3)<0.001
Table 6. Median [min–max] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) and PDF characteristics.
Table 6. Median [min–max] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) and PDF characteristics.
12345p
PDF intensity0.1 (−0.1–0.3)−0.1 (−1.5–0.6)−0.3 (−1.8–1.2) −0.2 (−2.2–0.9)−0.4 (−1.9–1.1)0.235
PDF duration−0.05 (−1.8–0.8)−0.3 (−2.2–1.1)−0.1 (−1.5–0.6)−0.3 (−1.8–1)−0.3 (−1.8–1.2)0.598
PDF frequency−0.1 (−1.8–0.6)−0.3 (−1.3–0.4)−0.1 (−2.2–0.6)−0.2 (−1.7–0.3)−0.3 (−2–1.2)0.986
Table 7. Median [95% CI] post-dialysis serum lactate levels (mmol/L) and median [95% CI] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) and TIRD.
Table 7. Median [95% CI] post-dialysis serum lactate levels (mmol/L) and median [95% CI] Δ post-dialysis/pre-dialysis serum lactate levels (mmol/L) and TIRD.
TIRD ≤ 12 h
(n = 70)
TIRD > 12 h
(n = 47)
Post-dialysis serum lactate levels1.1 (0.8–1.2)1.1 (0.7–1.3)0.665
Δ Post-dialysis/pre-dialysis serum lactate−0.2 (−0.3–0.1)−0.3 (−0.4–0.03)0.895
Table 8. Distribution of patients according to post-dialysis serum lactate levels and TIRD.
Table 8. Distribution of patients according to post-dialysis serum lactate levels and TIRD.
Post-Dialysis Serum Lactate LevelsTIRD ≤ 12 h
(n = 70)
TIRD > 12 h
(n = 47)
p
0.5–2.0 mmol/L67430.436
2.1–4.0 mmol/L34
≥4.0 mmol/L00
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bossola, M.; Ciferri, N.; Mariani, I.; Monteburini, T.; Santarelli, S.; Di Stasio, E. Post-Dialysis Fatigue Is Not Associated with Serum Lactate Levels in Patients on Chronic Hemodialysis. J. Clin. Med. 2025, 14, 2706. https://doi.org/10.3390/jcm14082706

AMA Style

Bossola M, Ciferri N, Mariani I, Monteburini T, Santarelli S, Di Stasio E. Post-Dialysis Fatigue Is Not Associated with Serum Lactate Levels in Patients on Chronic Hemodialysis. Journal of Clinical Medicine. 2025; 14(8):2706. https://doi.org/10.3390/jcm14082706

Chicago/Turabian Style

Bossola, Maurizio, Nunzia Ciferri, Ilaria Mariani, Tania Monteburini, Stefano Santarelli, and Enrico Di Stasio. 2025. "Post-Dialysis Fatigue Is Not Associated with Serum Lactate Levels in Patients on Chronic Hemodialysis" Journal of Clinical Medicine 14, no. 8: 2706. https://doi.org/10.3390/jcm14082706

APA Style

Bossola, M., Ciferri, N., Mariani, I., Monteburini, T., Santarelli, S., & Di Stasio, E. (2025). Post-Dialysis Fatigue Is Not Associated with Serum Lactate Levels in Patients on Chronic Hemodialysis. Journal of Clinical Medicine, 14(8), 2706. https://doi.org/10.3390/jcm14082706

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop